Pharmacokinetics and bioavailability of tuftsin-derived T peptide, a promising antitumor agent, in beagles

Drug Metabolism and Pharmacokinetics
Ruolan GuGuifang Dou

Abstract

Tuftsin, a natural phagocytosis-stimulating tetrapeptide, had aroused much interest in tumor immunotherapy, but the poor pharmacokinetics hampered its clinical developments, for that it was extremely susceptible to degradation by enzymolysis in vivo. T Peptide (TP) was a newly designed tuftsin derivative aimed to enhance stability and was proved to have significant antitumor activity. In this study, the pharmacokinetics and bioavailability of TP was first clarified in beagles with subcutaneous administration, by using a simple and robust competitive ELISA method. Dose-dependency and non-linear dynamics of TP after single-dose (2, 6 and 18 mg kg(-1), respectively) were found, and the half-time of TP was proved to reach 1.3-2.8 h. Multiple dosing of 6 mg kg(-1) once a day for 7 days resulted in a slight accumulation (accumulation index was 1.92 ± 0.43), indicating that the dosing interval in the following clinical trial needs to be extended. The absolute bioavailability of TP was 31.1 ± 6.2% after subcutaneous administration. These results first demonstrated the pharmacokinetics and bioavailability data of TP in vivo, which illustrated the potential druggability of TP and provided useful information for the dosage regimen design ...Continue Reading

References

Nov 14, 1970·Nature·V A Najjar, K Nishioka
Dec 4, 1981·Molecular and Cellular Biochemistry·K NishiokaR D Noyes
Aug 28, 1999·Peptides·I Z Siemion, A Kluczyk
Oct 23, 2004·Drug Metabolism and Pharmacokinetics·Hiroyuki TsudaMalcolm A Moore
Feb 28, 2006·Investigational New Drugs·Pierpaolo CorrealeGiorgio Giorgi
May 27, 2008·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Tathagata DuttaNarendra K Jain
Jun 26, 2009·Accounts of Chemical Research·Michael F Tweedle
Mar 24, 2011·Journal of Medicinal Chemistry·Magdalena Kukowska-KaszubaAndrzej Skladanowski
Jan 1, 2010·The Open Biomedical Engineering Journal·Tao HuangBo Huo
Sep 23, 2011·Biomaterials·Yingying XuYuanfang Liu
Sep 17, 2013·Journal of Neurochemistry·Jillian C NissenStella E Tsirka
Apr 10, 2014·Anti-cancer Drugs·Yinghong AnShoujun Yuan
Aug 13, 2014·Magnetic Resonance Insights·Naomi S Sta MariaRussell E Jacobs
Aug 19, 2014·Frontiers in Immunology·Asif Amin DarShubhada Vivek Chiplunkar
Sep 5, 2014·Cancer Immunology Research·Chad TangJames W Welsh
Sep 18, 2014·Cancer Management and Research·Michael Tronnier, Christina Mitteldorf

❮ Previous
Next ❯

Citations

Mar 30, 2019·British Journal of Clinical Pharmacology·Roger van GroenendaelPeter Pickkers

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.